Sensex: 85,106.81 (0.19%)

Nifty: 26,033.75 (0.18%)

anubhai angaldas Securities Pvt. Ltd. Member: BSE - NSE - CDSL

Technology . Transparency . Trust

Contact Us
Apply For IPO

MARKET

IPO Synopsis
Mahamaya Lifesciences Ltd
Registered Office: #DPT-033 Gr Flr Plt #79-80 DLF, Prime Tower F Blo.Okhla Phase1, New Delhi - 110020, New Delhi
Phone: 1
Email: 1
Website: 1
Initial public offer of up to 61,78,800 equity shares of face value of Rs. 10/- each ("equity shares") of Mahamaya Lifesciences Limited ("MLL" or the "company") for cash at price of Rs. 114/- per equity share (including a share premium of 104/- per equity share) (the "offer price"), aggregating up to Rs. 70.44 crores ("the offer"), comprising a fresh offer of upto 56,38,800 equity shares aggregating to Rs. 64.28 crores (the "fresh offer") and an offer for sale of upto 5,40,000 equity shares (the "offered shares") of face value of Rs. 10/- each aggregating up to Rs. 6.16 crores ("offer for sale") comprising of 3,70,000 equity shares aggregating up to Rs. 4.22 crores by Krishnamurthy Ganesan and 1,70,000 equity shares aggregating up to Rs. 1.94 crores by Lalitha Krishnamurthy (collectively referred to as the "selling shareholders") out of which 3,09,600 equity shares of face value of Rs. 10/- each, at an offer price of Rs. 114/- per equity share for cash, aggregating up to Rs. 3.53 crores will be reserved for subscription by the market maker to the offer ( the "market maker reservation portion"). The offer less market maker reservation portion i.e. net offer of 58,69,200 equity shares of face value of Rs. 10/- each, at an offer price of Rs. 114/- per equity share for cash, aggregating up to Rs. 66.91 crores is hereinafter referred to as the "net offer". The offer and net offer will constitute 26.40% and 25.08% respectively of the post-offer paid-up equity share capital of the company. The price band and the minimum bid lot will be decided by the company.
Issue Money Payable On
Opens On Closes On Application Allotment
11-Nov-2025 13-Nov-2025 114.00 - 0.00 0.00 - 0.00
Cr. Lead Managers to the Issue
Project Cost 61.96
Project Financed through Current Offer 70.44
Post Issue Equity Share Capital 23.41
Issue Price 114.00
Projects
Purchase of equipment for existing formulation plant
Funding capital expenditure towards setting up of a new technical manufacturing plant
Construction of warehouse building and purchase of machinery
Funding working capital requirement of the company
General corporate purposes
Promoted By
Krishnamurthy Ganesan
Lalitha Krishnamurthy
Prashant Krishnamurthy
BSE - SME
Registrar to the Issue
Attention Investor
As per CDSL communiqué Kindly update your Email ID, Mobile Number & Income Range in CDSL demat Account on or before 31st May 2021, Non Compliance Account will be INACTIVE after 31st May 2021. | Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors.  | "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account." | "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."    Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of Investors.